These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22499730)

  • 1. Double-robust estimators: slightly more Bayesian than meets the eye?
    Gustafson P
    Int J Biostat; 2012 Jan; 8(2):. PubMed ID: 22499730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A smooth ROC curve estimator based on log-concave density estimates.
    Rufibach K
    Int J Biostat; 2012; 8(1):. PubMed ID: 22611590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of model choices for the Continual Reassessment Method in phase I cancer trials.
    Paoletti X; Kramar A
    Stat Med; 2009 Oct; 28(24):3012-28. PubMed ID: 19672839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of random coefficient regression in accounting for residual confounding.
    Gustafson P; Greenland S
    Biometrics; 2006 Sep; 62(3):760-8. PubMed ID: 16984318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling for confounding in the presence of measurement error in hierarchical models: a Bayesian approach.
    Gryparis A; Coull BA; Schwartz J
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 2():S20-8. PubMed ID: 18079761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian nonparametric estimation of continuous monotone functions with applications to dose-response analysis.
    Bornkamp B; Ickstadt K
    Biometrics; 2009 Mar; 65(1):198-205. PubMed ID: 18510655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian inference for stochastic multitype epidemics in structured populations using sample data.
    O'Neill PD
    Biostatistics; 2009 Oct; 10(4):779-91. PubMed ID: 19648227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed-effects Gaussian process functional regression models with application to dose-response curve prediction.
    Shi JQ; Wang B; Will EJ; West RM
    Stat Med; 2012 Nov; 31(26):3165-77. PubMed ID: 22865484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A semi-parametric Bayesian approach to average bioequivalence.
    Ghosh P; Rosner GL
    Stat Med; 2007 Mar; 26(6):1224-36. PubMed ID: 16832840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian adjustment for exposure misclassification in case-control studies.
    Chu R; Gustafson P; Le N
    Stat Med; 2010 Apr; 29(9):994-1003. PubMed ID: 20087839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonparametric Bayesian inference for mean residual life functions in survival analysis.
    Poynor V; Kottas A
    Biostatistics; 2019 Apr; 20(2):240-255. PubMed ID: 29360946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mining pharmacovigilance data using Bayesian logistic regression with James-Stein type shrinkage estimation.
    An L; Fung KY; Krewski D
    J Biopharm Stat; 2010 Sep; 20(5):998-1012. PubMed ID: 20721787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coherent psychometric modelling with Bayesian nonparametrics.
    Karabatsos G; Walker SG
    Br J Math Stat Psychol; 2009 Feb; 62(Pt 1):1-20. PubMed ID: 17903345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parametric and nonparametric FDR estimation revisited.
    Wu B; Guan Z; Zhao H
    Biometrics; 2006 Sep; 62(3):735-44. PubMed ID: 16984315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of observational studies with unmeasured confounders.
    McCandless LC
    Int J Biostat; 2012 Jan; 8(2):. PubMed ID: 22499731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lead time distribution when lifetime is subject to competing risks in cancer screening.
    Wu D; Kafadar K; Rosner GL; Broemeling LD
    Int J Biostat; 2012; 8(1):. PubMed ID: 22611589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian versus frequentist hypotheses testing in clinical trials with dichotomous and countable outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2010 Sep; 20(5):985-97. PubMed ID: 20721786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation and asymptotic theory for transition probabilities in Markov renewal multi-state models.
    Spitoni C; Verduijn M; Putter H
    Int J Biostat; 2012 Aug; 8(1):23. PubMed ID: 22944722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size calculations for ROC studies: parametric robustness and Bayesian nonparametrics.
    Cheng D; Branscum AJ; Johnson WO
    Stat Med; 2012 Jan; 31(2):131-42. PubMed ID: 22139729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian nonparametric method for prediction in EST analysis.
    Lijoi A; Mena RH; Prünster I
    BMC Bioinformatics; 2007 Sep; 8():339. PubMed ID: 17868445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.